CG Oncology, Inc.
CGON- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001991792
In the last 90 days, CG Oncology, Inc. insiders filed 0 open-market purchases and 4 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $6.66B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in CG Oncology, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 140
- +20 vs. Q3 2024
- Shares held
- 66.2M
- +14.3M (+27.5%) vs. Q3 2024
- Total value
- $1.90B
- −$57.7M (−3.0%) vs. Q3 2024
- New holders
- 37
- 59 more added
- Sold out
- 17
- 27 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 227 | $6.66B |
| Q1 2026 | 233 | $6.03B |
| Q4 2025 | 195 | $3.43B |
| Q3 2025 | 176 | $3.13B |
| Q2 2025 | 163 | $1.97B |
| Q1 2025 | 142 | $1.74B |
| Q4 2024 | 140 | $1.90B |
| Q3 2024 | 121 | $1.96B |
| Q2 2024 | 111 | $1.37B |
| Q1 2024 | 96 | $1.70B |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding CG Oncology, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 308,259 | $8.84M | 0.02% | −437,804−58.7% | Reduced |
| Soleus Capital Management, L.P. | 328,585 | $9.42M | 0.71% | −12,000−3.5% | Reduced |
| Perceptive Advisors LLC | 419,450 | $12.0M | 0.34% | −314,245−42.8% | Reduced |
| Charles Schwab Investment Management Inc | 427,760 | $12.3M | 0.00% | +48,096+12.7% | Added |
| Northern Trust Corp | 433,860 | $12.4M | 0.00% | +52,419+13.7% | Added |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 495,526 | $14.2M | 32.51% | 00.0% | Unchanged |
| TimesSquare Capital Management, LLC | 546,904 | $15.7M | 0.23% | +109,835+25.1% | Added |
| Saturn V Capital Management LLC | 593,262 | $17.0M | 6.66% | +73,143+14.1% | Added |
| Woodline Partners LP | 628,885 | $18.0M | 0.12% | +22,987+3.8% | Added |
| Pictet Asset Management Holding SA | 674,607 | $19.3M | 0.02% | +674,607 | New |
| Foresite Capital Management V, LLC | 692,550 | $19.9M | 16.53% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 700,000 | $20.1M | 0.28% | 00.0% | Unchanged |
| Morgan Stanley | 725,227 | $20.8M | 0.00% | +490,356+208.8% | Added |
| Frazier Life Sciences Management, L.P. | 770,000 | $22.1M | 0.92% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 775,000 | $22.2M | 1.22% | −200,000−20.5% | Reduced |
| Goldman Sachs Group Inc | 818,667 | $23.5M | 0.00% | +169,093+26.0% | Added |
| Deerfield Management Company, L.P. (Series C) | 851,593 | $24.4M | 0.46% | +898+0.1% | Added |
| Price T Rowe Associates Inc | 945,194 | $27.1M | 0.00% | +353,787+59.8% | Added |
| Polar Capital Holdings Plc | 967,055 | $27.7M | 0.16% | 00.0% | Unchanged |
| UBS Group AG | 1,013,891 | $29.1M | 0.01% | +927,357+1,071.7% | Added |
| Avidity Partners Management LP | 1,097,800 | $31.5M | 3.14% | −558,200−33.7% | Reduced |
| Acorn Capital Advisors, LLC | 1,131,501 | $32.5M | 17.46% | +1,131,501 | New |
| Geode Capital Management, LLC | 1,156,670 | $33.2M | 0.00% | +78,143+7.2% | Added |
| Citadel Advisors LLC | 1,169,253 | $33.5M | 0.03% | +847,890+263.8% | Added |
| Franklin Resources Inc | 1,275,891 | $36.6M | 0.01% | +45,698+3.7% | Added |
| OrbiMed Advisors LLC | 1,431,114 | $41.0M | 0.85% | +740,000+107.1% | Added |
| Marshall Wace, LLP | 1,458,072 | $41.8M | 0.05% | +1,450,372+18,836.0% | Added |
| Janus Henderson Group PLC | 1,485,843 | $42.6M | 0.02% | −40,691−2.7% | Reduced |
| RTW Investments, LP | 1,701,216 | $48.8M | 0.74% | +357,142+26.6% | Added |
| Alliancebernstein L.P. | 1,817,887 | $52.1M | 0.02% | +692,982+61.6% | Added |
| Wellington Management Group LLP | 1,910,470 | $54.8M | 0.01% | +1,400,251+274.4% | Added |
| State Street Corp | 1,923,584 | $55.2M | 0.00% | +222,931+13.1% | Added |
| Foresite Capital Management VI LLC | 2,221,474 | $63.7M | 28.39% | +2,221,474 | New |
| FMR LLC | 2,433,593 | $69.8M | 0.00% | +2,287,987+1,571.4% | Added |
| Kynam Capital Management, LP | 2,519,705 | $72.3M | 4.77% | +748,900+42.3% | Added |
| Braidwell LP | 3,283,317 | $94.2M | 2.79% | +112,442+3.5% | Added |
| TCG Crossover Management, LLC | 3,670,206 | $105.3M | 10.29% | 00.0% | Unchanged |
| BlackRock, Inc. | 4,061,130 | $116.5M | 0.00% | +490,203+13.7% | Added |
| Vanguard Group Inc | 5,861,082 | $168.1M | 0.00% | +779,730+15.3% | Added |
| Decheng Capital LLC | 6,371,669 | $182.7M | 39.20% | +892,859+16.3% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,397,433−100.0% | Sold out |
| BVF Inc | 0 | $0 | 0.00% | −994,596−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −153,814−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −91,062−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −37,759−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −29,678−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −25,800−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −22,596−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −17,595−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −12,744−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −9,282−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −5,792−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −1,227−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Strengthening Families & Communities, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Ghost Tree Capital, LLC | – | – | – | – | Not filed |